Fine Organic Industries Limited has informed the Exchange regarding a press release dated May 20, 2026, titled "Press release on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026.".
FINEORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fine Organic Industries reported Q4FY26 consolidated revenue of Rs 625.3 crore (up 3.1% YoY) and full-year FY26 revenue of Rs 2,365.8 crore (up 4.3% YoY). EBITDA for FY26 stood at Rs 483.0 crore, down 5.8% from Rs 512.9 crore in FY25, with EBITDA margin compressing from 22.6% to 20.4%. PAT for FY26 was Rs 417.1 crore, up 1.6% YoY, boosted by a Rs 6.98 crore insurance claim for business interruption. The company expanded internationally by incorporating subsidiaries in the US (acquired ~160 acres of land in South Carolina), UAE (Dubai), and Thailand, while also approving the proposed acquisition of 80% stake in Oleofine Organics Sdn. Bhd., Malaysia for approximately Rs 83 crore. New labour code provisions required an incremental Rs 7.11 crore gratuity provision.
Revenue growth was modest at 4.3% for FY26, and the compression in EBITDA margin (22.6% to 20.4%) due to higher raw material and freight costs is a concern. However, strong Q4 PAT growth of 21% YoY and the strategic global expansion signal long-term growth intent, which may partially support investor sentiment.